Search by Drug Name or NDC
NDC 81964-0221-14 AMOXICILLIN AND CLAVULANATE POTASSIUM 875; 125 mg/1; mg/1 Details
AMOXICILLIN AND CLAVULANATE POTASSIUM 875; 125 mg/1; mg/1
AMOXICILLIN AND CLAVULANATE POTASSIUM is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by USAntibiotics, LLC. The primary component is AMOXICILLIN; CLAVULANATE POTASSIUM.
Product Information
| NDC | 81964-0221 |
|---|---|
| Product ID | 81964-221_d92713aa-67c3-477d-9fb8-ef54a948fd9a |
| Associated GPIs | |
| GCN Sequence Number | 024668 |
| GCN Sequence Number Description | amoxicillin/potassium clav TABLET 875-125 MG ORAL |
| HIC3 | W1A |
| HIC3 Description | PENICILLIN ANTIBIOTICS |
| GCN | 67076 |
| HICL Sequence Number | 003962 |
| HICL Sequence Number Description | AMOXICILLIN/POTASSIUM CLAVULANATE |
| Brand/Generic | Generic |
| Proprietary Name | AMOXICILLIN AND CLAVULANATE POTASSIUM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | amoxicillin and clavulanate potassium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, COATED |
| Route | ORAL |
| Active Ingredient Strength | 875; 125 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | AMOXICILLIN; CLAVULANATE POTASSIUM |
| Labeler Name | USAntibiotics, LLC |
| Pharmaceutical Class | Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA050720 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 81964-0221-14 (81964022114)
| NDC Package Code | 81964-221-14 |
|---|---|
| Billing NDC | 81964022114 |
| Package | 20 TABLET, COATED in 1 BOTTLE (81964-221-14) |
| Marketing Start Date | 2022-11-21 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.33968 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | AMOX-CLAV 875-125 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis